Diffuse alveolar hemorrhage: a narrative review

This review discusses clinical presentation of DAH, diagnosis the underlying histology’s, treatment options, as well morbidity and mortality rates. Diffuse alveolar hemorrhage (DAH) is considered a life-threatening pulmonary complication in patients with systemic autoimmune disorders, hematologic malignancies, coagulation disorders. DAH distinguished by acute onset hypoxia infiltrates that may lead to progressive bleeding. Early recognition are crucial for survival. Treatment involves treating both condition damage capillary membrane. The gold standard immunosuppressive agents corticosteroids. Despite early proper rates remain high.